Evidence map›Paper›PMID 31269912›Full record

ArticleBMC infectious diseases2019

Efficacy of pulsed-xenon ultraviolet light for disinfection of high-touch surfaces in an Ecuadorian hospital.

José E Villacís, Mario Lopez, Deborah Passey, Manuel Hernando Santillán, Germán Verdezoto, Freddy Trujillo, Gustavo Paredes, Carmen Alarcón, Ronny Horvath, Mark Stibich

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Use of Ozone for Disinfection of PHARMODUCTPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Potential of pulsed light technology for control of SARS-CoV-2 in hospital environments.Journal of photochemistry and photobiology. B, Biology · 2021
    Review
  11. Review
  12. Control of Methicillin-ResistantFrontiers in microbiology · 2020
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

José E VillacísScience department, 360Life Technologies, 6 de Diciembre y Batallas, Quito, Ecuador. eduardo.villacis@360life.tech.ORCID http://orcid.org/0000-0003-1478-5374
Mario LopezScience department, 360Life Technologies, 6 de Diciembre y Batallas, Quito, Ecuador.
Deborah PasseyXenex Disinfection Services, San Antonio, Texas, 78209, USA.
Manuel Hernando SantillánHospital Enrique Garcés, Quito, Ecuador.
Germán VerdezotoScience department, 360Life Technologies, 6 de Diciembre y Batallas, Quito, Ecuador.
Freddy TrujilloHospital Enrique Garcés, Quito, Ecuador.
Gustavo ParedesHospital Enrique Garcés, Quito, Ecuador.
Carmen AlarcónHospital Enrique Garcés, Quito, Ecuador.
Ronny HorvathScience department, 360Life Technologies, 6 de Diciembre y Batallas, Quito, Ecuador.
Mark StibichXenex Disinfection Services, San Antonio, Texas, 78209, USA.
Xenex Disinfection Services (United States) · USPontificia Universidad Católica del Ecuador · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHospital environment in patient care has been linked on healthcare-associated infections (HAI). No touch disinfection technologies that utilize pulsed xenon ultraviolet light has been recognized to prevent infection in contaminated environments. The purpose of this study was: 1) to evaluate the effectiveness of pulsed-xenon ultraviolet light (PX-UV) disinfection for the reduction of bacteria on environmental surfaces of Hospital General Enrique Garcés, and 2) to evaluate the in-vitro efficacy against multi-drug resistance microorganisms.

methodsThis was a quality-improvement study looking at cleaning and disinfection of patient areas. During the study, a total of 146 surfaces from 17 rooms were sampled in a secondary 329-bed public medical center. Microbiological samples of high-touch surfaces were taken after terminal manual cleaning and after pulsed xenon ultraviolet disinfection. Cleaning staff were blinded to the study purpose and told clean following their usual protocols. For positive cultures PCR identification for carbapenemase-resistance genes (blaKPC, blaIMP, blaVIM, and blaNDM) were analyzed and confirmed by sequencing. The total number of colony forming units (CFU) were obtained and statistical analyses were conducted using Wilcoxon Rank Sum tests to evaluate the difference in CFU between terminal manual cleaning and after pulsed xenon ultraviolet disinfection.

resultsAfter manual disinfection of 124 surfaces showed a total of 3569 CFU which dropped to 889 CFU in 80 surfaces after pulsed xenon disinfection (p < 0.001). Overall, the surface and environmental contamination was reduced by 75% after PX-UV compared to manual cleaning and disinfection. There were statistically significant decreases in CFU counts of high touch surfaces in OR 87% (p < 0.001) and patient rooms 76% (p < 0.001). Four rooms presented serine carbapenemases blaKPC, and metallo beta-lactamases blaNDM, blaVIM, blaIMP. confirmed by PCR and sequencing. The in-vitro testing with endemic strains found that after five minutes of pulsed xenon ultraviolet exposure an 8-log reduction was achieved in all cases.

conclusionThis study is one of the first of its kind in an Ecuador Hospital. We found that pulsed-xenon ultraviolet disinfection technology is an efficacious complement to the established manual cleaning protocols and guidelines in the significant reduction of MDRO.

Indexed as

HospitalsBacteriaBacterial Proteinsbeta-LactamasesColony Count, MicrobialCross InfectionDisinfectionDrug Resistance, BacterialEcuadorHumansPatients' RoomsUltraviolet RaysXenonBacterial Proteinsbeta-LactamasescarbapenemaseXenonCarbapenemaseDisinfectionEnvironmental surfacesHAIsUV-C light

Identifiers

PMID31269912
PMCPMC6609374
OpenAlexW2954275377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.